2010
DOI: 10.1016/j.vaccine.2010.08.083
|View full text |Cite
|
Sign up to set email alerts
|

Targeted microbeads for attraction and induction of specific innate immune response in the tumor microenvironment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 32 publications
0
8
0
Order By: Relevance
“…Polymeric solutions, micro-or nano-particulates can be used as effective adjuvants either alone [203] or in a complexed form with antigens [204] and/or other adjuvants [205]. Various polymers have been demonstrated to have such properties, such as polylactic acid (PLA), poly (lactide-co-glycolide) acid (PLGA) [206,207], chitosan [208][209][210][211] or modified chitosan [207], poly(-glutamic acid) (-PGA) [212,213], polypeptides [204], starch [214,215], polystyrene [35,205], polyphosphazene [216], poly (prolylene sulfide) [217], polyethylene glycol [218], alginate [219], and their copolymers [220,221].…”
Section: Polymeric Solutions or Particulatesmentioning
confidence: 99%
See 1 more Smart Citation
“…Polymeric solutions, micro-or nano-particulates can be used as effective adjuvants either alone [203] or in a complexed form with antigens [204] and/or other adjuvants [205]. Various polymers have been demonstrated to have such properties, such as polylactic acid (PLA), poly (lactide-co-glycolide) acid (PLGA) [206,207], chitosan [208][209][210][211] or modified chitosan [207], poly(-glutamic acid) (-PGA) [212,213], polypeptides [204], starch [214,215], polystyrene [35,205], polyphosphazene [216], poly (prolylene sulfide) [217], polyethylene glycol [218], alginate [219], and their copolymers [220,221].…”
Section: Polymeric Solutions or Particulatesmentioning
confidence: 99%
“…Various polymers have been demonstrated to have such properties, such as polylactic acid (PLA), poly (lactide-co-glycolide) acid (PLGA) [206,207], chitosan [208][209][210][211] or modified chitosan [207], poly(-glutamic acid) (-PGA) [212,213], polypeptides [204], starch [214,215], polystyrene [35,205], polyphosphazene [216], poly (prolylene sulfide) [217], polyethylene glycol [218], alginate [219], and their copolymers [220,221]. They enhance immunogenicity through several mechanisms, including enhancement of antigen uptake by dendritic cells (in vitro) [212], maturation of dendritic cells [212], promotion of proliferation of antigen-specific T cells [212], stimulation of both B and T lymphocytes [208], facilitation of activation of dendritic cells [222], viscosity-induced retention of antigens in the vaccination site [210] and controlled release of antigen by particles [223,224].…”
Section: Polymeric Solutions or Particulatesmentioning
confidence: 99%
“…Considerations in choosing MP size, shape and composition were previously discussed [34]. In this study, single ligands or their different combinations were attached to ~1.5-µm iron oxide MP.…”
Section: Discussionmentioning
confidence: 99%
“…Purified mIgG was biotinylated using EZ-Link Biotin LC sulfo-NHS (Pierce, Appleton, WI), and lipopolysaccharide (LPS; L-2654, Sigma-Aldrich) was biotinylated using EZ-Link biotin LC hydrazide (Pierce), as previously described [34,37]. The C5a receptor agonist hexapeptide (N-Methyl-Phe)-Lys-Pro-D-Cha-Cha-D-Arg-CO 2 H, described in detail by Konteatis et al [38], was synthesized with the addition of biotin at the C-terminal position (Gen-Script, Piscataway, NJ) and was designated C5a-pep.…”
Section: Preparation Of Immune-stimulating Ligands and Mp Assemblymentioning
confidence: 99%
See 1 more Smart Citation